There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be ...
On Tuesday, GSK plc (NYSE: GSK) released the headline results of the GLISTEN global phase 3 trial evaluating linerixibat in adults with cholestatic pruritus (relentless itch) associated with primary ...
EnteroBiotix's first-in-human study of EBX-102 was a randomised, double-blind, placebo-controlled Ph1b study of adult participants with stable liver cirrhosis. It was designed to evaluate the ...
EBX-102 demonstrated proof-of-principle across multiple microbiome assessments, inflammatory biomarkers and clinical assessments, supporting its continued development as the first microbial therapy ...
Elevated numbers can indicate liver damage or poor liver function. An additional test, called a GGT, may be added to the liver panel. This test can indicate that there is damage to the liver or ...
We'll be watching the election results all night with our panel. Joining Amna Nawaz and ... That's going to be the big test. So as we watch some of these numbers come out of Philadelphia, around ...
HRS-1 typically affects people with liver cirrhosis and is characterised by severe constriction of blood vessels in the kidney, leading to kidney failure. That in turn allows toxins such as ...
The virus, which can lead to conditions such as cardiovascular disease, mental health issues, kidney disease and musculoskeletal pain, is usually symptomless until it causes liver disease ...